BHR Biosynex is proud to announce an exclusive distribution agreement with Hangzhou AllTest Biotech Co. Ltd for the AFR-900 Fluorescence Immunoassay Analyser, bringing an innovative, compact point-of-care testing (POCT) solution to healthcare professionals across the UK.

The AFR-900 combines laboratory-level accuracy with true portability, making it an ideal solution for a wide range of care environments, from GP surgeries and community clinics to hospitals and ambulance services. Weighing less than 1.5 kg and equipped with a built-in battery, the analyser can be easily deployed wherever rapid, reliable results are needed.

Designed with healthcare professionals in mind, the AFR-900 delivers results in just 3–15 minutes, supporting faster clinical decision-making and improving patient flow. Its plug-and-play operation and intuitive 7-inch colour touch screen ensure ease of use with minimal training required, while seamless LIS compatibility enables straightforward data transfer. The system’s broad menu of tests covers key clinical areas including cardiac markers, inflammation, endocrinology, infectious diseases, and women’s health.

For patients, this means quicker answers, earlier interventions, and better outcomes - without the delays associated with central laboratory testing. By enabling clinicians to diagnose and manage conditions more efficiently, the AFR-900 helps to support improved standards of care and patient experience across diverse healthcare settings.

Wendy Thompson, Head of Marketing at BHR Biosynex, commented: “We are delighted to bring the AFR-900 to the UK market as part of our ongoing commitment to supporting healthcare professionals with innovative point-of-care testing solutions. This compact, versatile analyser offers both accuracy and speed, empowering clinicians to make timely decisions that directly benefit their patients.”

The exclusive distribution of the AFR-900 strengthens BHR Biosynex’s portfolio of advanced diagnostic solutions and underlines its position as a trusted partner in delivering high-quality, patient-focused innovations to the UK healthcare sector.

BHR Biosynex looks forward to showcasing the analyser on Stand 900 at the IBMS Congress in Birmingham, 22-25 September 2025, where healthcare professionals will be able to see live demonstrations and explore the system’s capabilities first-hand.

 The main features and benefits of the AFR-900 Fluorescence Immunoassay Analyser include:

• Compact & Portable Design – lightweight (<1.5 kg) with a built-in battery, ideal for use in GP surgeries, clinics, hospitals, and ambulances.
• Rapid Results – delivers reliable answers in just 3–15 minutes, with reading time under 20 seconds.
• Ease of Use – intuitive 7-inch colour touch screen and simple plug-and-play operation requiring minimal training.
• Broad Clinical Coverage – wide test menu including cardiac, inflammatory, endocrine, infectious disease, and tumour markers.
• Seamless Connectivity – POCT-ready with LIS compatibility and built-in thermal printer for efficient data management.
• Consistent Accuracy – europium-based fluorescence technology with rigorous self-checks for dependable performance.